Home / Health / New Hope: Cannabis Derivatives Target Deadly Ovarian Cancer
New Hope: Cannabis Derivatives Target Deadly Ovarian Cancer
15 Dec
Summary
- Cannabis compounds CBD and THC are being researched for ovarian cancer treatment.
- Researchers aim to reduce ovarian cancer toxicity with cannabis derivatives.
- Study results are preliminary and currently limited to in-vitro experiments.
Researchers at Khon Kaen University are exploring the potential of cannabis derivatives, including CBD and THC, to combat ovarian cancer. This effort seeks to develop alternative treatments that could offer improved efficacy and reduced toxicity compared to existing options, addressing a significant challenge in women's health. Ovarian cancer remains a leading cause of cancer death among women, often characterized by late diagnosis and limited treatment choices.
The preliminary research, conducted by Dr. Siyao Tong's team, focuses on the anti-cancer activity of CBD and THC. Their goal is to identify key molecular mechanisms that could pave the way for new therapeutic strategies. While these initial findings are promising, the study acknowledges its limitations, as all experiments have so far been conducted in vitro, meaning they do not fully represent the complexity of tumor behavior in living organisms.
